|
|
||||||||
in the newborn rat lung
Departments of 1Physiology, 2Obstetrics and Gynaecology, and 3Pediatrics, Canadian Institutes of Health Research Group in Perinatal Health and Disease, The Perinatal Research Centre, The University of Alberta, Edmonton, Alberta, Canada T6G 2S2
Submitted 19 August 2002 ; accepted in final form 6 March 2003
Signaling through the hypoxia inducible factor (HIF)-VEGF-VEGF receptor
system (VEGF signaling system) leads to angiogenesis and epithelial cell
proliferation and is a key mechanism regulating alveolarization in lungs of
newborn rats. Hyperoxia exposure (>95% O2 days
414) arrests lung alveolarization and may do so through
suppression of the VEGF signaling system. Lung tissue mRNA levels of
HIF-2
and VEGF increased from days 414 in normoxic
animals, but hyperoxia suppressed these increases. Levels of HIF-2
and
VEGF mRNA were correlated in the air but not the O2-treated group,
suggesting that the low levels of HIF-2
observed at high O2
concentrations are not stimulating VEGF expression. VEGF164 protein
levels increased with developmental age, and with hyperoxia to day 9,
but continuing hyperoxia decreased levels by day 12. VEGFR1 and
VEGFR2 mRNA expression also increased in air-exposed animals, and these, too,
were significantly decreased by hyperoxia by day 9 and day
12, respectively. Receptor protein levels did not increase with
development; however, O2 did decrease protein to less than air
values. Hyperoxic suppression of VEGF signaling from days 914
may be one mechanism by which alveolarization is arrested.
alveolarization; oxygen; septation
This article has been cited by other articles:
![]() |
J. Janer, S. Andersson, C. Haglund, R. Karikoski, and P. Lassus Placental Growth Factor and Vascular Endothelial Growth Factor Receptor-2 in Human Lung Development Pediatrics, August 1, 2008; 122(2): 340 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gien, G. J. Seedorf, V. Balasubramaniam, N. Markham, and S. H. Abman Intrauterine Pulmonary Hypertension Impairs Angiogenesis In Vitro: Role of Vascular Endothelial Growth Factor Nitric Oxide Signaling Am. J. Respir. Crit. Care Med., December 1, 2007; 176(11): 1146 - 1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Irwin, K. Helm, N. Campbell, M. Imamura, K. Fagan, J. Harral, M. Carr, K. A. Young, D. Klemm, S. Gebb, et al. Neonatal lung side population cells demonstrate endothelial potential and are altered in response to hyperoxia-induced lung simplification Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L941 - L951. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Grover, T. M. Asikainen, J. P. Kinsella, S. H. Abman, and C. W. White Hypoxia-inducible factors HIF-1{alpha} and HIF-2{alpha} are decreased in an experimental model of severe respiratory distress syndrome in preterm lambs Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1345 - L1351. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lopez, O. Boucherat, M.-L. Franco-Montoya, J. R. Bourbon, C. Delacourt, and P.-H. Jarreau Nitric Oxide Donor Restores Lung Growth Factor and Receptor Expression in Hyperoxia-Exposed Rat Pups Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 738 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, O. W. Moe, J. A. Garcia, and C. C. W. Hsia Regulated expression of hypoxia-inducible factors during postnatal and postpneumonectomy lung growth Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L880 - L889. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Voelkel, R. W. Vandivier, and R. M. Tuder Vascular endothelial growth factor in the lung Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L209 - L221. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Stenmark and V. Balasubramaniam Angiogenic Therapy for Bronchopulmonary Dysplasia: Rationale and Promise Circulation, October 18, 2005; 112(16): 2383 - 2385. [Full Text] [PDF] |
||||
![]() |
A. M. Kunig, V. Balasubramaniam, N. E. Markham, D. Morgan, G. Montgomery, T. R. Grover, and S. H. Abman Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L529 - L535. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. McGrath-Morrow, C. Cho, C. Cho, L. Zhen, D. J. Hicklin, and R. M. Tuder Vascular Endothelial Growth Factor Receptor 2 Blockade Disrupts Postnatal Lung Development Am. J. Respir. Cell Mol. Biol., May 1, 2005; 32(5): 420 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
Mechanisms and Limits of Induced Postnatal Lung Growth Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 319 - 343. [Full Text] [PDF] |
||||
![]() |
S. J. Merchant, I. P. Crocker, P. N. Baker, D. Tansinda, S. T. Davidge, and L. J. Guilberg Matrix Metalloproteinase Release From Placental Explants of Pregnancies Complicated by Intrauterine Growth Restriction Reproductive Sciences, February 1, 2004; 11(2): 97 - 103. [Abstract] [PDF] |
||||
![]() |
L. B. Clerch, A. S. Baras, G. D. Massaro, E. P. Hoffman, and D. Massaro DNA microarray analysis of neonatal mouse lung connects regulation of KDR with dexamethasone-induced inhibition of alveolar formation Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L411 - L419. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |